ClinicalTrials.Veeva

Menu

Virtual Reality in Aphasia Telerehabilitation

U

University of Oulu

Status

Not yet enrolling

Conditions

Aphasia, Acquired

Treatments

Behavioral: Treatment as usual
Behavioral: VR-treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT04828759
70/2020

Details and patient eligibility

About

The main purpose of this study is to evaluate the use of the immersive 3D HMD VR technology in the language intervention with a home-based telerehabilitation approach for people with aphasia. The assessments will be conducted at the baseline (prior the intervention periods) and after each intervention period (i.e. after the VR-intervention period and the waitlist period).

Full description

The purpose of the present project is to study the effects, feasibility, and the participants' experiences of this novel kind of language intervention. The effects of the intervention will be studied with various outcome measures in terms of language performance, functional communication, and quality of life. The aim is to explore the VR-intervention on the group level and with a randomized waitlist control group design (or delayed crossover design). In this study, the people with aphasia will be practicing at their home with support of their relatives, and participants will also receive regular remote guidance by a speech and language therapist (SLT) during the intervention. The relatives are also involved in the assessment process.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Post-stroke aphasia ≥ 3 months from stroke
  • Age 18-75 years
  • Finnish as a native language
  • Relative have the motivation and willingness to support person with aphasia in rehabilitation process
  • At least some level of spoken output
  • Moderate-to-severe aphasia
  • Deficit in a word retrieval process

Exclusion criteria

  • Participation in other intervention study during the study
  • Participation in other traditional speech and language therapy during the VR-intervention (i.e. 9-10 weeks period).
  • Severe and current psychotic disorder
  • Dementia/other neurodegenerative disease
  • History of previous stroke (/strokes) if not recovered, excluding TIAs (the criteria for the recovery: no residual aphasia or other disabilities caused by stroke which would affect in significant manner on everyday life)
  • Active epilepsy / migraine (< 3 years)
  • Severe apraxia of speech
  • Inability to act according to given instruction
  • Severe neuropsychological disorder or the decline of cognitive / memory functions, which would significantly affect for training during the VR-intervention
  • Vision or hearing impairment which would prevent the use of VR HMD
  • if the participant's treatment or medication is unsuitable with the use of VR HMD device as assessed by the physician
  • if the participant has the pacemaker or implantable (electric) medical device

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

20 participants in 2 patient groups

VR-treatment, then Treatment as usual
Experimental group
Description:
Participants will receive 8 weeks of VR-treatment. Participants are allowed to practice as much as they wish during the VR-intervention. However, they are given a recommendation of the amount of practice (5 h / week). Before the VR-intervention, the participants will receive a guidance for using the VR-devices (i.e. orientation period) by the SLT. Participants will be able to contact the SLT freely during the 8 weeks VR-intervention period. After the orientation period, the participants will be practicing at their homes independently. However, they will receive remote guidance by the SLT. The guidance includes weekly remote guidance sessions by SLT (8 x 45 min) to ensure that training is fluent and unproblematic. Additionally, the content of exercises can be modified during these sessions. The SLT is also able to monitor the training of participants with the system. Devices: VR headset and controller, Tablet computer.
Treatment:
Behavioral: VR-treatment
Treatment as usual, then VR-treatment
Experimental group
Description:
Wait list control group: During the waitlist period the participants will receive the traditional speech and language therapy rehabilitation offered by (if offered) the general health care system in their own home municipality. The amount of rehabilitation is not controlled during the wait list period. However, the amount of received traditional speech and language rehabilitation in waitlist period will be documented. The waitlist control group will receive the same VR intervention period after the 8 weeks waitlist period.
Treatment:
Behavioral: Treatment as usual

Trial contacts and locations

0

Loading...

Central trial contact

Emilia Malinen, MA; Matti Lehtihalmes, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems